News Post List
In the news this week: NHS waiting times for cancer treatment ‘continue to spiral downwards’.
A dual kinase inhibitor is entering a clinical trial for advanced pancreatic cancer in combination with gemcitabine.
One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland.
In the news this week: The low-down from the world’s largest cancer conference and the dangerous documentaries spreading misinformation about cancer.
A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy.
An immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food pipe.
Combining a targeted drug with hormone therapy extended the lives of pre-menopausal women with advanced breast cancer in a clinical trial.
The 2019 ASCO conference news highlights: a year of progress with targeted drugs trialled in prostate, pancreatic, breast and lung cancers.
With more women dying from lung cancer than ever before, we need to better understand the links between gender and health.
We look at the research made possible by people who donate their bodies after their death, including helping scientists understand how advanced cancers spread.